FALL 2020 CIHR COMPETITION RESULTS
RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research
New study in Quebec long-term care facilities
Dr. Don Vinh continues his work to understand why some people are more vulnerable to COVID-19
Honouring leadership excellence in Montreal with a $1 million donation
Dr. Don Sheppard is the inaugural recipient of The Legge Orr MI4 Leadership Award
COVID-19 in prisons: understanding the spread of the disease
Since the start of the pandemic, COVID-19 rates in Canadian correctional facilities have been...
RI-MUHC researchers support Canada’s efforts to address the COVID-19 pandemic
Drs. Emily McDonald and Todd C. Lee are part of the Canadian Network of COVID-19 Clinical Trials Networks...
Zombie cells and flu fighters
Research by postdoc Hosni Cherif and Dr. Inés Colmegna makes Arthritis Society’s Top 10 breakthroughs
Overcoming vaccine hesitancy
Our best hope of charting a course to a post-pandemic world
New study of hydroxychloroquine usage may help personalize lupus treatment
RI-MUHC researchers identify factors associated with poor outcomes for lupus patients
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...